Ackman to Testify at Senate Drug-Pricing Hearing

Corrected

Bill Ackman.

Photographer: Andrew Harrer/Bloomberg

Bill Ackman, the billionaire activist investor, will testify before a Senate panel Wednesday on prescription-drug pricing as lawmakers probe practices at troubled Valeant Pharmaceuticals International Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.